Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-04-01

Clinical Trial Update: Study Of Oral Elagolix Tablets To Assess the Tolerability and Change in Disease Symptoms in Adult Female Participants With Moderate to Severe Endometriosis-associated Pain

View source ↗

Summary

This is a completed clinical trial evaluating tolerability and changes in symptoms for oral elagolix in adult women with moderate-to-severe endometriosis-associ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Orilissa (elagolix)

Snippet

Sponsor: AbbVie | Conditions: Endometriosis | Status: COMPLETED